{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:52:05Z","timestamp":1781761925571,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32473065"],"award-info":[{"award-number":["32473065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32273025"],"award-info":[{"award-number":["32273025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32272966"],"award-info":[{"award-number":["32272966"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2024JC-ZDXM-15"],"award-info":[{"award-number":["2024JC-ZDXM-15"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yangling demonstration zone science and technology plan project","award":["2024NY-13"],"award-info":[{"award-number":["2024NY-13"]}]},{"name":"Shaanxi Provincial Innovation Capability Support Plan","award":["2023-CX-TD-60"],"award-info":[{"award-number":["2023-CX-TD-60"]}]},{"name":"Shaanxi Livestock and Poultry Breeding Double-chain Fusion Key Project","award":["2022GD-TSLD-46-0503"],"award-info":[{"award-number":["2022GD-TSLD-46-0503"]}]},{"DOI":"10.13039\/501100005236","name":"Chinese Universities Scientific Fund","doi-asserted-by":"publisher","award":["2452023072"],"award-info":[{"award-number":["2452023072"]}],"id":[{"id":"10.13039\/501100005236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Canine parvovirus-2 (CPV-2) and canine distemper virus (CDV) are two highly infectious and pathogenic pathogens that harm canids and various carnivores, and often cause co-infections in clinical settings. Although commercial attenuated live vaccines against CPV-2 and CDV have been widely used to prevent these viral infections, there are still issues of biosafety and insufficient protection against new variants, thus requiring novel vaccines. In this study, we developed a recombinant pseudovirus expression system based on the CPV-2 full-length infectious clone, and found that the recombinant CPV-2 pseudovirus expressing CDV H protein could efficiently protect dogs against both CPV-2 and CDV infections. We first designed a recombinant pseudovirus vector based on the CPV-2 backbone and established a stable cell system for the production of CPV-2 recombinant pseudoviruses carrying foreign genes. These pseudoviruses preserved the morphology and particle size of native CPV-2, while maintaining hemagglutination activity against porcine erythrocytes, and demonstrated the ability to effectively infect permissive cells to express the harbored foreign gene. Next, we produced a recombinant CPV-2 pseudovirus expressing CDV H protein, and the CPV\u2013CDV recombinant pseudovirus induced effective cellular and humoral immune responses in dogs. The serum from CPV\u2013CDV immunized dogs could effectively neutralize CPV-2 and CDV infections in susceptible cells. Importantly, CPV\u2013CDV completely protected dogs against challenge with CPV-2 and CDV. In summary, we have successfully developed a stable production system of recombinant CPV-2 pseudoviruses, which has great potential for development as a vaccine platform.<\/jats:p>","DOI":"10.1186\/s13567-026-01789-9","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:01:44Z","timestamp":1781758904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of canine parvovirus-2-based recombinant pseudoviruses expression system: a potential vaccine platform"],"prefix":"10.1186","volume":"57","author":[{"given":"Bichen","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"1789_CR1","volume":"286","author":"A Behdenna","year":"2019","unstructured":"Behdenna A, Lembo T, Calatayud O, Cleaveland S, Halliday JEB, Packer C, Lankester F, Hampson K, Craft ME, Czupryna A, Dobson AP, Dubovi EJ, Ernest E, Fyumagwa R, Hopcraft JGC, Mentzel C, Mzimbiri I, Sutton D, Willett B, Haydon DT, Viana M (2019) Transmission ecology of canine parvovirus in a multi-host, multi-pathogen system. Proc Biol Sci 286:20182772","journal-title":"Proc Biol Sci"},{"key":"1789_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02532-21","volume":"10","author":"CN Kimpston","year":"2022","unstructured":"Kimpston CN, Hatke AL, Castelli B, Otto N, Tiffin HS, Machtinger ET, Brown JD, Van Why KR, Marconi RT (2022) High prevalence of antibodies against canine parvovirus and canine distemper virus among coyotes and foxes from Pennsylvania: implications for the intersection of companion animals and wildlife. Microbiol Spectr 10:e0253221","journal-title":"Microbiol Spectr"},{"key":"1789_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7589\/2018-07-175","volume":"55","author":"A Justice-Allen","year":"2019","unstructured":"Justice-Allen A, Clement MJ (2019) Effect of canine parvovirus and canine distemper virus on the Mexican wolf (Canis lupus baileyi) population in the USA. J Wildl Dis 55:682\u2013688","journal-title":"J Wildl Dis"},{"key":"1789_CR4","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1111\/tbed.14370","volume":"69","author":"R Wang","year":"2022","unstructured":"Wang R, Wang X, Zhai J, Zhang P, Irwin DM, Shen X, Chen W, Shen Y (2022) A new canine distemper virus lineage identified from red pandas in China. Transbound Emerg Dis 69:e944\u2013e952","journal-title":"Transbound Emerg Dis"},{"key":"1789_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2025.1624275","volume":"12","author":"H Li","year":"2025","unstructured":"Li H, Li S, Pan Y, Shi Q (2025) Decoding canine parvovirus: biomarkers for diagnosis and advances in vaccine development to address emerging challenges. Front Vet Sci 12:1624275","journal-title":"Front Vet Sci"},{"key":"1789_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1748-5827.2007.00462.x","volume":"48","author":"MJ Day","year":"2007","unstructured":"Day MJ, Horzinek MC, Schultz RD (2007) Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract 48:528\u2013541","journal-title":"J Small Anim Pract"},{"key":"1789_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08462-4","volume":"7","author":"H Zhang","year":"2017","unstructured":"Zhang H, Shan F, Zhou X, Li B, Zhai JQ, Zou SZ, Wu MF, Chen W, Zhai SL, Luo ML (2017) Outbreak and genotyping of canine distemper virus in captive Siberian tigers and red pandas. Sci Rep 7:8132","journal-title":"Sci Rep"},{"key":"1789_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79806-0","volume":"14","author":"Z Fang","year":"2024","unstructured":"Fang Z, Shi H, Wang Q, Liu Z, Tu S, Wang Y, Wu Y, Liu G, Jin Y (2024) Risk of canine distemper virus vaccination of domestic dogs in giant panda habitat to giant pandas. Sci Rep 14:29761","journal-title":"Sci Rep"},{"key":"1789_CR9","doi-asserted-by":"crossref","unstructured":"Candela MG, Wipf A, Ortega N, Huertas-L\u00f3pez A, Mart\u00ednez-Carrasco C, Perez-Cutillas P (2025) Tracking the spatial and functional dispersion of vaccine-related canine distemper virus genotypes: insights from a global scoping review.\u00a0Viruses 17:1045","DOI":"10.3390\/v17081045"},{"key":"1789_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01856-22","volume":"10","author":"P Fu","year":"2022","unstructured":"Fu P, He D, Cheng X, Niu X, Wang C, Fu Y, Li K, Zhu H, Lu W, Wang J, Chu B (2022) Prevalence and characteristics of canine parvovirus type 2 in Henan Province, China. Microbiol Spectr 10:e0185622","journal-title":"Microbiol Spectr"},{"key":"1789_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105633","volume":"123","author":"S Grecco","year":"2024","unstructured":"Grecco S, Condon E, Bucafusco D, Bratanich AC, Panzera Y, P\u00e9rez R (2024) Comparative genomics of canine parvovirus in South America: diversification patterns in local populations. Infect Genet Evol 123:105633","journal-title":"Infect Genet Evol"},{"key":"1789_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11259-025-10750-8","volume":"49","author":"HTT Doan","year":"2025","unstructured":"Doan HTT, Nguyen KT, Do RT, Duc LM, Tiem PV, Le TH (2025) Phylogenetic and sequence analysis of the co-circulating lineages in the canine distemper virus complexity from Northern Vietnam (2017\u20132023). Vet Res Commun 49:186","journal-title":"Vet Res Commun"},{"key":"1789_CR13","doi-asserted-by":"crossref","unstructured":"Hao X, Li Y, Xiao X, Chen B, Zhou P, Li S (2022) The Changes in Canine Parvovirus Variants over the Years. Int J Mol Sci 23","DOI":"10.3390\/ijms231911540"},{"key":"1789_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67781-5","volume":"14","author":"S Rendon-Marin","year":"2024","unstructured":"Rendon-Marin S, Ru\u00edz-Saenz J (2024) Universal peptide-based potential vaccine design against canine distemper virus (CDV) using a vaccinomic approach. Sci Rep 14:16605","journal-title":"Sci Rep"},{"key":"1789_CR15","doi-asserted-by":"crossref","unstructured":"Paul B, Alam J, Hossain MMK, Hoque SF, Bappy MNI, Akter H, Ahmed N, Akter M, Ali Zinnah M, Das S, Mia MM, Parvej MS, Sarkar S, Ghosh H, Hasan M, Ashour HM, Rahman MM (2023) Immunoinformatics for novel multi-epitope vaccine development in canine parvovirus infections. Biomedicines 11:2180","DOI":"10.3390\/biomedicines11082180"},{"key":"1789_CR16","doi-asserted-by":"crossref","unstructured":"Zhou H, Cui K, Su X, Zhang H, Xiao B, Li S, Yang B (2024) Overview of recent advances in canine parvovirus research: current status and future perspectives. Microorganisms 13:47","DOI":"10.3390\/microorganisms13010047"},{"key":"1789_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399404008026","volume":"6","author":"B Blechacz","year":"2004","unstructured":"Blechacz B, Russell SJ (2004) Parvovirus vectors: use and optimisation in cancer gene therapy. Expert Rev Mol Med 6:1\u201324","journal-title":"Expert Rev Mol Med"},{"key":"1789_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G (2024) Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther 9:78","journal-title":"Signal Transduct Target Ther"},{"key":"1789_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jgm.653","volume":"7","author":"K El Bakkouri","year":"2005","unstructured":"El Bakkouri K, Servais C, Cl\u00e9ment N, Cheong SC, Franssen JD, Velu T, Brandenburger A (2005) In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA. J Gene Med 7:189\u2013197","journal-title":"J Gene Med"},{"key":"1789_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/v9110321","author":"N Pittman","year":"2017","unstructured":"Pittman N, Misseldine A, Geilen L, Halder S, Smith JK, Kurian J, Chipman P, Janssen M, Mckenna R, Baker TS, D\u2019Abramo A Jr, Cotmore S, Tattersall P, Agbandje-McKenna M (2017) Atomic resolution structure of the oncolytic parvovirus LuIII by electron microscopy and 3D image reconstruction. Viruses 9:321","journal-title":"Viruses"},{"key":"1789_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v14051018","author":"T Ferreira","year":"2022","unstructured":"Ferreira T, Kulkarni A, Bretscher C, Nazarov PV, Hossain JA, Ystaas LAR, Miletic H, R\u00f6th R, Niesler B, Marchini A (2022) Oncolytic H-1 parvovirus hijacks Galectin-1 to enter cancer cells. Viruses 14:1018","journal-title":"Viruses"},{"key":"1789_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00297-25","volume":"99","author":"K Busuttil","year":"2025","unstructured":"Busuttil K, Pittman N, Zachary J, Halder S, Geilen L, Singh A, Misseldine A, Kaplonek P, Chipman P, Heimburg-Molinaro J, Seeberger PH, Mietzsch M, Bennett AD, McKenna R (2025) Mapping the sialic acid-binding sites of LuIII and H-1 parvovirus. J Virol 99:e0029725","journal-title":"J Virol"},{"key":"1789_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/v17030333","author":"M Mietzsch","year":"2025","unstructured":"Mietzsch M, Bennett A, McKenna R (2025) Structural capsidomics of single-stranded DNA viruses. Viruses 17:333","journal-title":"Viruses"},{"key":"1789_CR24","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1016\/j.ymthe.2021.04.005","volume":"29","author":"J Fakhiri","year":"2021","unstructured":"Fakhiri J, Grimm D (2021) Best of most possible worlds: hybrid gene therapy vectors based on parvoviruses and heterologous viruses. Mol Ther 29:3359\u20133382","journal-title":"Mol Ther"},{"key":"1789_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-0716-1012-1_5","volume":"2225","author":"RB Ridley","year":"2021","unstructured":"Ridley RB, Walsh EM, Ildefonso CJ (2021) Molecular design and production of AAV viral vectors for gene therapy. Methods Mol Biol 2225:77\u201392","journal-title":"Methods Mol Biol"},{"key":"1789_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2022.101765","volume":"82","author":"D Tuteja","year":"2022","unstructured":"Tuteja D, Banu K, Mondal B (2022) Canine parvovirology - a brief updated review on structural biology, occurrence, pathogenesis, clinical diagnosis, treatment and prevention. Comp Immunol Microbiol Infect Dis 82:101765","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"1789_CR27","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1128\/JVI.76.4.1884-1891.2002","volume":"76","author":"M Vihinen-Ranta","year":"2002","unstructured":"Vihinen-Ranta M, Wang D, Weichert WS, Parrish CR (2002) The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J Virol 76:1884\u20131891","journal-title":"J Virol"},{"key":"1789_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2021.109301","volume":"264","author":"B Miao","year":"2022","unstructured":"Miao B, Chen S, Zhang X, Ma P, Ma M, Chen C, Zhang X, Chang L, Du Q, Huang Y, Tong D (2022) T598 and T601 phosphorylation sites of canine parvovirus NS1 are crucial for viral replication and pathogenicity. Vet Microbiol 264:109301","journal-title":"Vet Microbiol"},{"key":"1789_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-4939-3389-1_23","volume":"1404","author":"X Zhou","year":"2016","unstructured":"Zhou X, Xiang Z, Ertl HCJ (2016) Vaccine design: replication-defective adenovirus vectors. Methods Mol Biol 1404:329\u2013349","journal-title":"Methods Mol Biol"},{"key":"1789_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/v16071094","author":"M Salauddin","year":"2024","unstructured":"Salauddin M, Saha S, Hossain MG, Okuda K, Shimada M (2024) Clinical application of adenovirus (AdV): a comprehensive review. Viruses 16:1094","journal-title":"Viruses"},{"key":"1789_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li C, Samulski RJ (2020) Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet 21:255\u2013272","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1789_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","volume":"28","author":"ME Dieterle","year":"2020","unstructured":"Dieterle ME, Haslwanter D, Bortz RH 3rd, Wirchnianski AS, Lasso G, Vergnolle O, Abbasi SA, Fels JM, Laudermilch E, Florez C, Mengotto A, Kimmel D, Malonis RJ, Georgiev G, Quiroz J, Barnhill J, Pirofski LA, Daily JP, Dye JM, Lai JR, Herbert AS, Chandran K, Jangra RK (2020) A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. Cell Host Microbe 28:486\u2013496","journal-title":"Cell Host Microbe"},{"key":"1789_CR33","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1128\/JVI.00519-11","volume":"85","author":"J Ge","year":"2011","unstructured":"Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z (2011) Newcastle Disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol 85:8241\u20138252","journal-title":"J Virol"},{"key":"1789_CR34","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1016\/j.ymthe.2024.10.017","volume":"32","author":"JH Wang","year":"2024","unstructured":"Wang JH, Zhan W, Gallagher TL, Gao G (2024) Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: a comprehensive review. Mol Ther 32:4185\u20134207","journal-title":"Mol Ther"},{"key":"1789_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1566523043346228","volume":"4","author":"JJ Cornelis","year":"2004","unstructured":"Cornelis JJ, Lang SI, Stroh-Dege AY, Balboni G, Dinsart C, Rommelaere J (2004) Cancer gene therapy through autonomous parvovirus\u2013mediated gene transfer. Curr Gene Ther 4:249\u2013261","journal-title":"Curr Gene Ther"},{"key":"1789_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2023.109978","volume":"290","author":"M Yang","year":"2024","unstructured":"Yang M, Jiao Y, Li L, Yan Y, Fu Z, Liu Z, Hu X, Li M, Shi Y, He J, Shen Z, Peng G (2024) A potential dual protection vaccine: recombinant feline herpesvirus-1 expressing feline parvovirus VP2 antigen. Vet Microbiol 290:109978","journal-title":"Vet Microbiol"},{"key":"1789_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/v12121463","author":"C Ros","year":"2020","unstructured":"Ros C, Bieri J, Leisi R (2020) The VP1u of human parvovirus B19: a multifunctional capsid protein with biotechnological applications. Viruses 12:1463","journal-title":"Viruses"},{"key":"1789_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12985-023-02102-2","volume":"20","author":"S Sarabandi","year":"2023","unstructured":"Sarabandi S, Pourtaghi H (2023) Whole genome sequence analysis of CPV-2 isolates from 1998 to 2020. Virol J 20:138","journal-title":"Virol J"},{"key":"1789_CR39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1128\/JVI.75.3.1284-1293.2001","volume":"75","author":"N Cl\u00e9ment","year":"2001","unstructured":"Cl\u00e9ment N, Avalosse B, El Bakkouri K, Velu T, Brandenburger A (2001) Cloning and sequencing of defective particles derived from the autonomous parvovirus Minute virus of mice for the construction of vectors with minimal cis-acting sequences. J Virol 75:1284\u20131293","journal-title":"J Virol"},{"key":"1789_CR40","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1128\/JVI.02598-10","volume":"85","author":"P Plevka","year":"2011","unstructured":"Plevka P, Hafenstein S, Li L, D\u2019Abrgamo A Jr, Cotmore SF, Rossmann MG, Tattersall P (2011) Structure of a packaging-defective mutant of minute virus of mice indicates that the genome is packaged via a pore at a 5-fold axis. J Virol 85:4822\u20134827","journal-title":"J Virol"},{"key":"1789_CR41","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/10430349950018210","volume":"10","author":"A Brandenburger","year":"1999","unstructured":"Brandenburger A, Coessens E, El Bakkouri K, Velu T (1999) Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors. Hum Gene Ther 10:1229\u20131238","journal-title":"Hum Gene Ther"},{"key":"1789_CR42","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1016\/j.vaccine.2013.06.062","volume":"31","author":"S Chandramouli","year":"2013","unstructured":"Chandramouli S, Medina-Selby A, Coit D, Schaefer M, Spencer T, Brito LA, Zhang P, Otten G, Mandl CW, Mason PW, Dormitzer PR, Settembre EC (2013) Generation of a parvovirus B19 vaccine candidate. Vaccine 31:3872\u20133878","journal-title":"Vaccine"},{"key":"1789_CR43","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/sj.gt.3301477","volume":"8","author":"F Dupont","year":"2001","unstructured":"Dupont F, Karim A, Dumon JC, Mine N, Avalosse B (2001) A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination. Gene Ther 8:921\u2013929","journal-title":"Gene Ther"},{"issue":"Suppl 1","key":"1789_CR44","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1002\/jgm.504","volume":"6","author":"A Brandenburger","year":"2004","unstructured":"Brandenburger A, Velu T (2004) Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus. J Gene Med 6:S203\u2013S211","journal-title":"J Gene Med"},{"key":"1789_CR45","doi-asserted-by":"crossref","unstructured":"Thimmiraju SR, Villar MJ, Kimata JT, Strych U, Bottazzi ME, Hotez PJ, Pollet J (2024) Optimization of cellular transduction by the HIV-based pseudovirus platform with pan-coronavirus spike proteins. Viruses 16:1492","DOI":"10.3390\/v16091492"},{"key":"1789_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2463191","volume":"21","author":"A Bardach","year":"2025","unstructured":"Bardach A, Brizuela M, Berrueta M, Ciapponi A, Sambade JM, Ballivian J, Ortega V, Castellana N, Comand\u00e9 D, Parker EPK, Kampmann B, Stegelmann K, Xiong X, Stergachis A, Munoz FM, Buekens P, Mazzoni A (2025) Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines. Hum Vaccin Immunother 21:2463191","journal-title":"Hum Vaccin Immunother"},{"key":"1789_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12030324","author":"S Meas","year":"2024","unstructured":"Meas S, Chaimongkolnukul K, Narkpuk J, Mekvichitsaeng P, Poomputsa K, Wanasen N, Roshorm YM (2024) Humoral and cellular immune responses induced by bivalent DNA vaccines expressing fusion capsid proteins of Porcine Circovirus genotypes 2a and 2b. Vaccines 12:324","journal-title":"Vaccines Basel"},{"key":"1789_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.crpvbd.2025.100272","volume":"7","author":"W Junsiri","year":"2025","unstructured":"Junsiri W, Taweethavonsawat P (2025) New insights into the genetic diversity, phylogeny, and immunogenic potential of the wsp gene in Wolbachia endosymbionts in Brugia malayi and Brugia pahangi. Curr Res Parasitol Vector Borne Dis 7:100272","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"1789_CR49","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.4049\/jimmunol.165.6.3136","volume":"165","author":"KM Smith","year":"2000","unstructured":"Smith KM, Pottage L, Thomas ER, Leishman AJ, Doig TN, Xu D, Liew FY, Garside P (2000) Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol 165:3136\u20133144","journal-title":"J Immunol"},{"key":"1789_CR50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","volume":"38","author":"M Ruterbusch","year":"2020","unstructured":"Ruterbusch M, Pruner KB, Shehata L, Pepper M (2020) In vivo CD4(+) T cell differentiation and function: revisiting the Th1\/Th2 paradigm. Annu Rev Immunol 38:705\u2013725","journal-title":"Annu Rev Immunol"},{"key":"1789_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","volume":"19","author":"S Nooraei","year":"2021","unstructured":"Nooraei S, Bahrulolum H, Hoseini ZS, Katalani C, Hajizade A, Easton AJ, Ahmadian G (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J Nanobiotechnol 19:59","journal-title":"J Nanobiotechnol"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-026-01789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-026-01789-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-026-01789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:01:48Z","timestamp":1781758908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13567-026-01789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1186\/s13567-026-01789-9","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}